Alnylam Pharmaceuticals
ALNY
#788
Rank
HK$244.32 B
Marketcap
HK$1,826
Share price
3.63%
Change (1 day)
-49.05%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Cash on Hand

Cash on Hand as of June 2026 : HK$25.95 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company has HK$25.95 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Alnylam Pharmaceuticals - Cash on Hand chart (from 2003 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31HK$22.62 B8.18%
2024-12-31HK$20.91 B9.8%
2023-12-31HK$19.05 B11.22%
2022-12-31HK$17.12 B-9.8%
2021-12-31HK$18.99 B30.7%
2020-12-31HK$14.53 B21.46%
2019-12-31HK$11.96 B40.92%
2018-12-31HK$8.48 B-35.72%
2017-12-31HK$13.20 B171.75%
2016-12-31HK$4.86 B-41.96%
2015-12-31HK$8.37 B54.98%
2014-12-31HK$5.40 B183.43%
2013-12-31HK$1.90 B100.28%
2012-12-31HK$0.95 B-16.28%
2011-12-31HK$1.13 B-37.33%
2010-12-31HK$1.81 B-16.85%
2009-12-31HK$2.18 B-34.39%
2008-12-31HK$3.32 B9.39%
2007-12-31HK$3.04 B79.93%
2006-12-31HK$1.68 B172.42%
2005-12-31HK$0.62 B73.34%
2004-12-31HK$0.35 B99.05%
2003-12-31HK$0.17 B48.95%
2002-12-31HK$0.12 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novartis
NVS
HK$60.34 B 132.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$56.87 B 119.08%๐Ÿ‡ซ๐Ÿ‡ท France
Regeneron Pharmaceuticals
REGN
HK$62.73 B 141.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$6.18 B-76.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
HK$0.51 B-98.02%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
HK$2.36 B-90.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$28.68 B 10.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Arrowhead Pharmaceuticals
ARWR
HK$12.57 B-51.58%๐Ÿ‡บ๐Ÿ‡ธ USA